ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia

National Institute of Dental and Craniofacial Research (NIDCR) · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
fibrous dysplasia of bone, mccune-albright syndrome, rickets, osteomalacia, metabolic bone disorders, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 801389
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.